Scientists looking at the genetic code of leukaemia cells believe they have found a possible new therapeutic approach targeting ‘noncoding RNAs’.
These molecules are produced through gene transcription, and are not translated into proteins but have regulatory functions such as cell growth and cell division.
Now, a German research team have found a noncoding RNAs which could be a potential weakness in acute myeloid leukaemia (AML) cells.
The team, led by Dr Jan-Henning Klusmann and Prof Dirk Heckl from Goethe University in Frankfurt, focused on non-coding RNAs, because cancer cells typically show a massive disruption of regulatory processes. They made an inventory of these molecules in AML cells to compare the differences to healthy blood...
10 hours ago